We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Centralized Review of Some Nationally Authorized APIs Now Required in EU
Centralized Review of Some Nationally Authorized APIs Now Required in EU
The European Medicines Agency now requires centralized review of periodic safety update reports for active pharmaceutical substances found only in medicines authorized at the country level.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor